Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C27H39NO2 |
| Molecular Weight | 409.6041 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H]([C@@H]1NC[C@@H](C)C[C@H]1O)C2=C(C)C3=C(C=C2)[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4C3
InChI
InChIKey=MALFODICFSIXPO-KFKQDBFTSA-N
InChI=1S/C27H39NO2/c1-15-11-25(30)26(28-14-15)17(3)20-7-8-21-22-6-5-18-12-19(29)9-10-27(18,4)24(22)13-23(21)16(20)2/h5,7-8,15,17,19,22,24-26,28-30H,6,9-14H2,1-4H3/t15-,17-,19-,22-,24-,25+,26-,27-/m0/s1
| Molecular Formula | C27H39NO2 |
| Molecular Weight | 409.6041 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Veratramine, a steroidal alkaloid originating from Veratrum nigrum L. CYP2D6 and SULT2A1 mediating hydroxylation and sulfation were identified as the major biotransformation for veratramine. Veratramine significantly inhibits the hedgehog pathway in NIH/3T3 cells. Veratramine is both a release and uptake inhibitor of serotonin. Veratramine exhibits cytotoxic activity against human tumor cell lines A549, PANC-1, SW1990 and NCI-H249. Veratramine has demonstrated distinct anti-hypertension effects in spontaneously hypertensive rats.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0001820 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1710298 |
|||
Target ID: GO:0051610 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1710298 |
0.25 µM [Ki] | ||
Target ID: CHEMBL289 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25765359 |
33.0 µM [Ki] | ||
Target ID: CHEMBL2077 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25765359 |
|||
Target ID: map04340 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20013819 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Characterization and identification of steroidal alkaloids in Fritillaria species using liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry. | 2010-11-05 |
|
| Hedgehog antagonist cyclopamine isomerizes to less potent forms when acidified. | 2010-09-05 |
|
| Antitumor and antiplatelet activity of alkaloids from veratrum dahuricum. | 2010-06 |
|
| Synthesis of all diastereomers of the piperidine--alkaloid substructure of cyclopamine. | 2009-12-03 |
|
| [Steroidal alkaloids of from Veratrum dahuricum]. | 2009-12 |
|
| Hypotensive effect and toxicology of total alkaloids and veratramine from roots and rhizomes of Veratrum nigrum L. in spontaneously hypertensive rats. | 2008-08 |
|
| Antitumor activity of extracts and compounds from the rhizomes of Veratrum dahuricum. | 2008-08 |
|
| Isolation, purification, and full NMR assignments of cyclopamine from Veratrum californicum. | 2008-06-24 |
|
| [Determination of vetatramine in Veratrum nigrum by HPLC-ELSD]. | 2008-04 |
|
| [Determination of jervine and veratramine in Veratrum plants using high performance liquid chromatography coupled with evaporative light scattering detection]. | 2008-01 |
|
| Development of in vitro techniques for the important medicinal plant Veratrum californicum. | 2006-10 |
|
| Puqienine F, a novel veratramine alkaloid from the bulbs of Fritillaria puqiensis. | 2006-05 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18771011
0.56 to 2.24 mg/kg
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1710298
The uptake of 3H-5-HT into the frontal cortical slices was inhibited by veratramine in a concentration-dependent fashion with an IC50 of 0.13 uM.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:26:47 GMT 2025
by
admin
on
Mon Mar 31 23:26:47 GMT 2025
|
| Record UNII |
RK363YG315
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
23880
Created by
admin on Mon Mar 31 23:26:47 GMT 2025 , Edited by admin on Mon Mar 31 23:26:47 GMT 2025
|
PRIMARY | |||
|
Dieldrin
Created by
admin on Mon Mar 31 23:26:47 GMT 2025 , Edited by admin on Mon Mar 31 23:26:47 GMT 2025
|
PRIMARY | |||
|
RK363YG315
Created by
admin on Mon Mar 31 23:26:47 GMT 2025 , Edited by admin on Mon Mar 31 23:26:47 GMT 2025
|
PRIMARY | |||
|
3545
Created by
admin on Mon Mar 31 23:26:47 GMT 2025 , Edited by admin on Mon Mar 31 23:26:47 GMT 2025
|
PRIMARY | |||
|
6070
Created by
admin on Mon Mar 31 23:26:47 GMT 2025 , Edited by admin on Mon Mar 31 23:26:47 GMT 2025
|
PRIMARY | |||
|
m11416
Created by
admin on Mon Mar 31 23:26:47 GMT 2025 , Edited by admin on Mon Mar 31 23:26:47 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID40871534
Created by
admin on Mon Mar 31 23:26:47 GMT 2025 , Edited by admin on Mon Mar 31 23:26:47 GMT 2025
|
PRIMARY | |||
|
17821
Created by
admin on Mon Mar 31 23:26:47 GMT 2025 , Edited by admin on Mon Mar 31 23:26:47 GMT 2025
|
PRIMARY | |||
|
9951
Created by
admin on Mon Mar 31 23:26:47 GMT 2025 , Edited by admin on Mon Mar 31 23:26:47 GMT 2025
|
PRIMARY | |||
|
60-70-8
Created by
admin on Mon Mar 31 23:26:47 GMT 2025 , Edited by admin on Mon Mar 31 23:26:47 GMT 2025
|
PRIMARY |